Literature DB >> 1810146

The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo.

W A Schumacher1, J C Fantone, S E Kunkel, R C Webb, B R Lucchesi.   

Abstract

The effect of complement fragments on coronary blood flow in vivo and the contraction of coronary arteries in vitro was determined. In pentobarbital anesthetized dogs, intraarterial bolus injection of C3a and C5a, zymosan-activated serum and methylcholine in the coronary vascular bed caused transient and dose-dependent increases in coronary blood flow. Similar increases were obtained with 25 micrograms of C3a (104 +/- 13%, n = 5) and 0.1 microgram of methylcholine (102 +/- 4%, n = 3). Smaller increases in blood flow were elicited by 25 micrograms of C5a (41 +/- 18%, n = 4) and 0.2 ml of zymosan-activated serum (48 +/- 5%, n = 4). None of these responses were associated with significant changes in left ventricular contractile force measured with a strain gauge, arterial blood pressure, and heart rate. C3a dilated the coronary vascular bed in conscious dogs with an activity equal to or greater than that observed in anesthetized dogs. Isolated canine coronary arteries that were precontracted with serotonin relaxed in response to C3a, whether or not the endothelium was intact. Overall these data suggest that physiologically high doses of anaphylactic complement fragments vasodilate the canine coronary circulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1810146     DOI: 10.1007/BF01988727

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  18 in total

1.  Augmentation of streptokinase-induced thrombolysis by heparin and prostacyclin.

Authors:  W A Schumacher; E C Lee; B R Lucchesi
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.105

2.  Role of thromboxane A2 in the cardiovascular response to intracoronary C5a.

Authors:  G L Stahl; E A Amsterdam; J D Symons; J C Longhurst
Journal:  Circ Res       Date:  1990-04       Impact factor: 17.367

3.  Cardiac dysfunction caused by purified human C3a anaphylatoxin.

Authors:  U H del Balzo; R Levi; M J Polley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 4.  Anaphylatoxins: C3a and C5a.

Authors:  T E Hugli; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

5.  C5a decreases regional coronary blood flow and myocardial function in pigs: implications for a granulocyte mechanism.

Authors:  S E Martin; D E Chenoweth; R L Engler; D M Roth; J C Longhurst
Journal:  Circ Res       Date:  1988-08       Impact factor: 17.367

6.  Microvascular effects of anaphylatoxins C3a and C5a.

Authors:  J Björk; T E Hugli; G Smedegård
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

7.  Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.

Authors:  P R Maroko; C B Carpenter; M Chiariello; M C Fishbein; P Radvany; J D Knostman; S L Hale
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips.

Authors:  T E Hugli; F Marceau
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

9.  Anaphylatoxin-induced shock and two patterns of anaphylactic shock: hemodynamics and mediators.

Authors:  K Pavek; P J Piper; G Smedegård
Journal:  Acta Physiol Scand       Date:  1979-04

10.  The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats.

Authors:  J H Hill; P A Ward
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Complement in ischemia reperfusion injury.

Authors:  Niels C Riedemann; Peter A Ward
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 2.  Current and future concepts of abdominal sepsis.

Authors:  Klaus Emmanuel; Heike Weighardt; Holger Bartels; Jorg-Rudiger Siewert; Bernhard Holzmann
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

3.  Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Bo H Yoon; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Pooja Mittal; Offer Erez; Francesca Gotsch; Moshe Mazor; Juan P Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

4.  Anaphylatoxins in preterm and term labor.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Jyh Kae Nien; Tinnakorn Chaiworapongsa; Joaquin Santolaya-Forgas; Samuel S Edwin; Moshe Mazor
Journal:  J Perinat Med       Date:  2005       Impact factor: 1.901

5.  Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy.

Authors:  Eleazar Soto; Karina Richani; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Luis Goncalves; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

6.  Normal pregnancy is characterized by systemic activation of the complement system.

Authors:  Karina Richani; Eleazar Soto; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

Review 7.  Role of complement 3 in the pathogenesis of hypertension.

Authors:  Lan Chen; Noboru Fukuda; Taro Matsumoto; Masanori Abe
Journal:  Hypertens Res       Date:  2019-12-18       Impact factor: 3.872

8.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Sam S Edwin; Yeon Mee Kim; Joon Seok Hong; Luis F Goncalves; Lami Yeo; Moshe Mazor; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

Review 9.  Complement components as potential therapeutic targets for asthma treatment.

Authors:  Mohammad Afzal Khan; Mark R Nicolls; Besiki Surguladze; Ismail Saadoun
Journal:  Respir Med       Date:  2014-01-15       Impact factor: 3.415

10.  Increased C5a receptor expression in sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Thomas A Neff; Ines J Laudes; Katie A Keller; Vidya J Sarma; Maciej M Markiewski; Dimitrios Mastellos; Christoph W Strey; Carl L Pierson; John D Lambris; Firas S Zetoune; Peter A Ward
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.